This information sheet provides concise information for primary care health professionals, based on the National Asthma Council’s updated Australian Asthma Handbook.
For patients with a clinically significant asthma exacerbation, prompt treatment with systemic corticosteroids is indicated to avoid escalation to emergency department attendance, hospitalisation, or life-threatening acute asthma – but we must not encourage people to regard these as a harmless alternative to prevention.
Growing evidence highlights the risks associated with repeated short courses, even at relatively low cumulative doses. Many Australians accumulate a harmful lifetime dose. Systemic corticosteroid exposure can be minimised by:
OCS use indicates the need for a full asthma review to optimise preventive treatment.
View the information sheet by accessing the download button above.
Disclaimer
Although all care has been taken, this information is a general guide only, which is not a substitute for assessment of appropriate courses of treatment on a case-by-case basis. The National Asthma Council Australia expressly disclaims all responsibility (including for negligence) for any loss, damage or personal injury resulting from reliance on the information contained herein.
Acknowledgements
Developed by the National Asthma Council Australia in collaboration with:
Clinical Associate Professor Debbie Rigby
Advanced practice pharmacist
Dr Amanda Lucci
General practitioner
Dr Tom Skinner
Respiratory physician
Dr Kim Watkins
Pharmacist
This information was developed independently by the National Asthma Council Australia with support from Chiesi Australia and AstraZeneca Australia.
© National Asthma Council Australia 2026

An essential guide to selecting and adjusting asthma medication for adults and adolescents available in Australia, updated December 2025.

An information sheet for health professionals based on the Australian Asthma Handbook